Alexander Ditchfield
Managing Director, Head of New York
New York
Alexander Ditchfield is a Managing Director and Head of BDA’s New York office. Clients for whom he has advised on transactions include Aterian Investment Partners, CHS, CITIC Capital, Kerry, Littlejohn, On Semi, MacLean-Fogg, Molex, and Pfizer, among others.
Prior to moving to New York in 2016, he worked in BDA’s Shanghai and Hong Kong offices for seven years. He speaks Mandarin and English.
Recent transactions
acquired majority stake in
2024
Health
received investment from
2023
Industrials
a portfolio company of
has been sold to
2023
Industrials
divested Niigata fab to
Sangyo Sosei and Fukuoka Capital
2022
Industrials
acquired by
a portfolio company of
2022
Chemicals
has been acquired by
2022
Technology
divested ASG Print to
and
2021
Industrials
has been acquired by
2021
Chemicals
divested China phenolic resins plant to
2021
Chemicals
divested to
a portfolio company of
2020
Chemicals
Presswerk Krefeld a portfolio company of
has been acquired by
2017
Industrials
raised equity capital and new Asian partnerships
2016
Chemicals
CHS Ningbo Protein Foods a subsidiary of CHS has been acquired by
Shandong Wonderful
2016
Consumer
a portfolio company of
has been acquired by
2016
Industrials
divested
to
2014
Industrials
divested
to American Tire Distributors
2014
Industrials
divested KDM to Superior Capital Partners / Nelson-Miller
2012
Industrials